The Relevance of Serum Albumin Among Elderly Patients With Acute Decompensated Heart Failure

Authors

Tuoyo O. Mene-Afejuku, New York Medical College
Ela-Anamaria Moisa, New York Medical College
Adedoyin Akinlonu, New York Medical College
Carissa Dumancas, New York Medical College
Shushan Veranyan
Jose A. Perez, New York Medical College
Peggy Salazar, New York Medical College
Shobhana Chaudhari, New York Medical CollegeFollow
Gerald Pekler, New York Medical CollegeFollow
Savi Mushiyev, New York Medical CollegeFollow
Ferdinand Visco, New York Medical CollegeFollow

Journal Title

Journal of Geriatric Cardiology

First Page

522

Last Page

528

Document Type

Article

Publication Date

July 2019

Department

Medicine

Abstract

Objective: To assess the prognostic utility of serum albumin among elderly patients admitted for acute decompensated heart failure (ADHF) in terms of all-cause mortality and also to identify the predictors of hypoalbuminemia. Methods: Retrospective cohort study of 119 elderly patients admitted for ADHF. Elderly patients were defined as patients over the age of 65 years. The patients were followed up for approximately 11 years. Patients with advanced renal failure, liver disease not due to HF, cancer and other causes of low life expectancy were excluded. Hypoalbuminemia was defined as serum albumin

Recommended Citation

Mene-Afejuku, T. O., Moisa, E., Akinlonu, A., Dumancas, C., Veranyan, S., Perez, J., Salazar, P., Chaudhari, S., Pekler, G., Mushiyev, S., & Visco, F. (2019). The Relevance of Serum Albumin Among Elderly Patients With Acute Decompensated Heart Failure. Journal of Geriatric Cardiology, 16 (7), 522-528. https://doi.org/10.11909/j.issn.1671-5411.2019.07.005